Navigation Links
Life Sciences Discovery Fund makes grants to commercialize promising technologies
Date:9/3/2014

SEATTLE, Washington, August 29, 2014 The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace. Also announced was nearly $56,000 in supplemental funding to an existing grant to increase the commercial potential of a drug to protect hearing in patients taking certain antibiotics. (See Backgrounder Information.)

The LSDF Board of Trustees selected the awardees following review of proposals for scientific and technical merit, commercial potential, and health and economic benefits to Washington.

The three new Proof of Concept awards will advance the development of products to improve lupus treatment and to permit at-home monitoring of lung function for individuals with asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions. Funding also will support validation of novel cell separations technology for cancer immunotherapy and other medical and research applications.

"We are excited to make additional investments in the areas of autoimmune disorders and cancer and to expand our grant-making reach into lung disease management," said John DesRosier, LSDF executive director.

Board chair Carol Dahl concurred, noting that "LSDF is pleased to support the burgeoning field of mobile health technology, which represents a powerful tool for improving the overall quality and cost-effectiveness of our health-care system."

Additionally, the grant supplement of $55,990 to the University of Washington (principal investigator Edwin Rubel) will fund critical preclinical studies of a drug that appears to prevent the hearing loss associated with certain commonly used antibiotics.

LSDF is now accepting pre-proposals from Washington for-profit and non-profit organizations for the 2014-2015 Matching and Proof of Concept granting programs. The next pre-proposal submission deadline for both programs is January 7, 2015. For more details, please visit the LSDF website at http://www.lsdfa.org/, email programs@lsdfa.org, or call 206-456-9577.

Funding for the new awards comes from Washington's allocation of payments under the Master Tobacco Settlement Agreement of 1998, revenues arising from multi-state litigation with tobacco product manufacturers.


'/>"/>
Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

Related medicine news :

1. Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards
2. Liberty University Dedicates Its New Center for Medical and Health Sciences
3. Lauren Sciences LLC research team at Ben-Gurion University awarded grant from The ALS Association to develop V-Smart™ Therapeutic for ALS
4. Drexel College of Medicine’s Graduate School of Biomedical Sciences & Professional Studies to Host Conference to Help Graduate Students Find Careers Beyond the Bench
5. AxoGen, Inc. to Present at the Wedbush 2014 Life Sciences Management Access Conference
6. NSU’s Graduate School of Computer and Information Sciences to Host ITPalooza
7. Register to Join the Merrill DataSite's Webinar - Built to Sell: The Life Sciences Deal Climate
8. Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic
9. 5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing
10. Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll
11. NSU’s Graduate School of Computer and Information Sciences to Hold Special Presentations on Top 5 Technology Trends to Impact Business & IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: